Cargando…

Molecular Research on Drug Induced Liver Injury

Detalles Bibliográficos
Autores principales:	Teschke, Rolf, Danan, Gaby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796165/ https://www.ncbi.nlm.nih.gov/pubmed/29324638 http://dx.doi.org/10.3390/ijms19010216

Ejemplares similares

RUCAM in Drug and Herb Induced Liver Injury: The Update
por: Danan, Gaby, et al.
Publicado: (2015)

Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
por: Teschke, Rolf, et al.
Publicado: (2021)

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
por: Danan, Gaby, et al.
Publicado: (2019)

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
por: Teschke, Rolf, et al.
Publicado: (2021)

Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
por: Teschke, Rolf, et al.
Publicado: (2023)

Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
por: Teschke, Rolf, et al.
Publicado: (2017)

The LiverTox Paradox-Gaps between Promised Data and Reality Check
por: Teschke, Rolf, et al.
Publicado: (2021)

Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?
por: Teschke, Rolf, et al.
Publicado: (2018)

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
por: Teschke, Rolf, et al.
Publicado: (2020)

Treatment of Drug-Induced Liver Injury
por: Teschke, Rolf
Publicado: (2022)

Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury
por: Jing, Jing, et al.
Publicado: (2017)

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
por: Teschke, Rolf, et al.
Publicado: (2016)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Traditional Chinese Medicine Induced Liver Injury
por: Teschke, Rolf
Publicado: (2014)

Hepatotoxicity: Molecular Mechanisms and Pathophysiology
por: Teschke, Rolf
Publicado: (2019)

Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations
por: Teschke, Rolf
Publicado: (2023)

Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
por: Teschke, Rolf, et al.
Publicado: (2013)

Drug, Herb, and Dietary Supplement Hepatotoxicity
por: Teschke, Rolf, et al.
Publicado: (2016)

Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017)

Aliphatic Halogenated Hydrocarbons: Report and Analysis of Liver Injury in 60 Patients
por: Teschke, Rolf
Publicado: (2018)

Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury
por: Teschke, Rolf
Publicado: (2022)

Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects
por: Teschke, Rolf
Publicado: (2018)

Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases
por: Teschke, Rolf, et al.
Publicado: (2020)

Liver Injury by Carbon Tetrachloride Intoxication in 16 Patients Treated with Forced Ventilation to Accelerate Toxin Removal via the Lungs: A Clinical Report
por: Teschke, Rolf
Publicado: (2018)

Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury
por: Neuman, Manuela G., et al.
Publicado: (2022)

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
por: Teschke, Rolf, et al.
Publicado: (2022)

Editorial of Special Column on Drug- and Chemical-Induced Liver Injury
por: Luyendyk, James, et al.
Publicado: (2021)

Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support
por: Teschke, Rolf, et al.
Publicado: (2019)

Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance
por: Teschke, Rolf
Publicado: (2019)

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same
por: Olry, Alexandre, et al.
Publicado: (2020)

Active Pharmacovigilance of Drug-Induced Liver Injury Using Electronic Health Records
por: Kim, Sang-Heon
Publicado: (2020)

Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study
por: Melchart, Dieter, et al.
Publicado: (2017)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges
por: Teschke, Rolf, et al.
Publicado: (2016)

Dissecting the molecular pathophysiology of drug-induced liver injury
por: Ye, Hui, et al.
Publicado: (2018)

Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?
por: Jang, Byoung Kuk
Publicado: (2022)

Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury
por: Kim, Seung-Hyun, et al.
Publicado: (2016)

Role of Autophagy in Ehrlichia-Induced Liver Injury
por: Sharma, Aditya Kumar, et al.
Publicado: (2023)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
por: Weber, Sabine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vu0ujsfsu1if64olops8257uc6